Hematopoietic Stem Cell Transplant

Part of the Specialty Topics in Pediatric Neuropsychology book series (STPN)

Abstract

Children treated with hematopoietic stem cell transplantation (HSCT), particularly allogeneic HSCT, are at particular risk for late effects of therapy. Chronic graft-versus-host disease (cGVHD) is a major cause of morbidity in these survivors. In addition, the source of stem cells and the transplant conditioning regimen (which may include both chemotherapy and total body irradiation) impact survivors’ long-term risks. These risks are frequently compounded by the types of cancer therapy received prior to the transplant. Survivors of allogeneic transplant require lifelong follow-up by a medical team with expertise in this population. This care is directed by guidelines such as those published by the Children’s Oncology Group. Since most body systems can be impacted by HSCT and its therapy, long-term care frequently involves input from multiple medical sub-specialists. Co-ordination of this care through a cancer survivor or HSCT clinic can optimize long-term medical and psychosocial outcomes in HSCT survivors.

Keywords

Hematopoietic cell transplant Graft-versus-host disease Late effects Surveillance 

References

  1. 1.
    Coppes, M. J., Fry, T. J., & Mackall, C. L. (2010). Hematopoietic stem cell transplantation. Pediatric Clinics North America, 57, XVII–IXXGoogle Scholar
  2. 2.
    Armenian, S. H., Sun, C. L., Kawashima, T., Arora, M., Leisenring, W., Sklar, C. A., et al. (2011). Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: A report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood, 118, 1413–1420.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Bhatia, S., Francisco, L., Carter, A., Sun, C. L., Baker, K. S., Gurney, J. G., et al. (2007). Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood, 110, 3784–3792.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Barrett, D., Fish, J. D., & Grupp, S. A. (2010). Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. Pediatric Clinics of North America, 57, 47–66.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Bresters, D., van Gils, I. C., Kollen, W. J., Ball, L. M., Oostdijk, W., van der Bom, J. G., et al. (2010). High burden of late effects after haematopoietic stem cell transplantation in childhood: A single-centre study. Bone Marrow Transplantation, 45, 79–85.PubMedGoogle Scholar
  6. 6.
    Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., et al. (2005). National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation, 11, 945–956.PubMedGoogle Scholar
  7. 7.
    Ferrara, J. L., & Deeg, H. J. (1991). Graft-versus-host disease. New England Journal of Medicine, 324, 667–674.PubMedGoogle Scholar
  8. 8.
    Matzinger, P. (2002). The danger model: A renewed sense of self. Science, 296, 301–305.PubMedGoogle Scholar
  9. 9.
    Versluys, A. B., Rossen, J. W., van Ewijk, B., Schuurman, R., Bierings, M. B., & Boelens, J. J. (2010). Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes. Biology of Blood and Marrow Transplantation, 16, 782–791.PubMedGoogle Scholar
  10. 10.
    Storb, R., Prentice, R. L., Sullivan, K. M., Shulman, H. M., Deeg, H. J., Doney, K. C., et al. (1983). Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Annals of Internal Medicine, 98, 461–466.PubMedGoogle Scholar
  11. 11.
    Ringdén, O., Paulin, T., Lönnqvist, B., & Nilsson, B. (1985). An analysis of factors predisposing to chronic graft-versus-host disease. Experimental Hematology, 13, 1062–1067.PubMedGoogle Scholar
  12. 12.
    Atkinson, K. (1990). Chronic graft-versus-host disease. Bone Marrow Transplantation, 5, 69–82.PubMedGoogle Scholar
  13. 13.
    Ochs, L. A., Miller, W. J., Filipovich, A. H., Haake, R. J., McGlave, P. B., Blazar, B. R., et al. (1994). Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplantation, 13, 455–460.PubMedGoogle Scholar
  14. 14.
    Zecca, M., Prete, A., Rondelli, R., Lanino, E., Balduzzi, A., Messina, C., et al. (2002). Chronic graft-versus-host disease in children: Incidence, risk factors, and impact on outcome. Blood, 100, 1192.PubMedGoogle Scholar
  15. 15.
    Lee, S. J., Klein, J. P., Barrett, A. J., Ringden, O., Antin, J. H., Cahn, J. Y., et al. (2002). Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse. Blood, 100, 406–414.PubMedGoogle Scholar
  16. 16.
    Goerner, M., Gooley, T., Flowers, M. E., Sullivan, K. M., Kiem, H. P., Sanders, J. E., et al. (2002). Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology of Blood and Marrow Transplantation, 8, 47–56.PubMedGoogle Scholar
  17. 17.
    Atkinson, K., Horowitz, M. M., Gale, R. P., van Bekkum, D. W., Gluckman, E., Good, R. A., et al. (1990). Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood, 15, 2459–2464.Google Scholar
  18. 18.
    Eapen, M., Horowitz, M. M., Klein, J. P., Champlin, R. E., Loberiza, F. R. J., Ringdén, O., et al. (2004). Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Journal of Clinical Oncology, 22, 4872–4880.PubMedGoogle Scholar
  19. 19.
    Higman, M. A., & Vogelsand, G. B. (2004). Chronic graft versus host disease. British Journal of Haematology, 125, 435–454.PubMedGoogle Scholar
  20. 20.
    Rocha, V., Wagner, J. E., Jr., Sobocinski, K. A., Klein, J. P., Zhang, M. J., Horowitz, M. M., et al. (2000). Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. New England Journal of Medicine, 22, 1846–1854.Google Scholar
  21. 21.
    Carpenter, P. A. (2008). Late effects of chronic graft-versus-host disease. Best Practice & Research Clinical Haematology, 21, 309–331.Google Scholar
  22. 22.
    Lee, S. J., Kim, H. T., Ho, V. T., Cutler, C., Alyea, E. P., Soiffer, R. J., et al. (2006). Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplantation, 38, 305–310.PubMedGoogle Scholar
  23. 23.
    Baker, K. S., & Fraser, C. J. (2008). Quality of life and recovery after graft-versus-host disease. Practice and Research Clinical Haematology, 21, 333–341.Google Scholar
  24. 24.
    Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., et al. (1980). Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. The American Journal of Medicine, 69, 204–217.Google Scholar
  25. 25.
    Akpek, G., Zahurak, M. L., Piantadosi, S., et al. (2001). Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 97, 1219–1226.PubMedGoogle Scholar
  26. 26.
    Lee, S., Cook, E. F., Soiffer, R., & Antin, J. H. (2002). Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 8, 444–452.PubMedGoogle Scholar
  27. 27.
    Stewart, B. L., Storer, B., Storek, J., Deeg, H. J., Storb, R., Hansen, J. A., et al. (2004). Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood, 104, 3501–3506.PubMedGoogle Scholar
  28. 28.
    Eikenberry, M., Bartakova, H., Defor, T., Haddad, I. Y., Ramsay, N. K., Blazar, B. R., et al. (2005). Natural history of pulmonary complications in children after bone marrow transplantation. Biology of Blood and Marrow Transplantation, 11, 56–64.PubMedGoogle Scholar
  29. 29.
    Clark, J. G., Crawford, S. W., Madtes, D. K., & Sullivan, K. M. (1989). Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Annals of Internal Medicine, 111, 368–376.PubMedGoogle Scholar
  30. 30.
    Fanfulla, F., Locatelli, F., Zoia, M. C., Giorgiani, G., Bonetti, F., Spagnolatti, L., et al. (1997). Pulmonary complications and respiratory function changes after bone marrow transplantation in children. European Respiratory Journal, 10, 2301–2306.PubMedGoogle Scholar
  31. 31.
    Cerveri, I., Zoia, M. C., Fulgoni, P., Corsico, A., Casali, L., Tinelli, C., et al. (1999). Late pulmonary sequelae after childhood bone marrow transplantation. Bone Marrow Transplantation, 41, 971–975.Google Scholar
  32. 32.
    Duncan, C. N., Buonanno, M. R., Barry, E. V., Myers, K., Peritz, D., & Lehmann, L. (2008). Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 41, 971–975.PubMedGoogle Scholar
  33. 33.
    Holland, H. K., Wingard, J. R., Beschorner, W. E., Saral, R., & Santos, G. W. (1988). Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood, 72, 621–627.PubMedGoogle Scholar
  34. 34.
    Dudek, A. Z., Mahaseth, H., DeFor, T. E., & Weisdorf, D. J. (2003). Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes. Biology of Blood and Marrow Transplantation, 9, 657–666.PubMedGoogle Scholar
  35. 35.
    Yoshihara, S., Tateishi, U., Ando, T., Kunitoh, H., Suyama, H., Onishi, Y., et al. (2005). Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplantation, 35, 1195.PubMedGoogle Scholar
  36. 36.
    Sakaida, E., Nakaseko, C., Harima, A., Yokota, A., Cho, R., Saito, Y., et al. (2003). Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graftversus-leukemia effect. Blood, 102, 4236–4242.PubMedGoogle Scholar
  37. 37.
    Santo Tomas, L. H., Loberiza, F. R. J., Klein, J. P., Layde, P. M., Lipchik, R. J., Rizzo, J. D, et al. (2005). Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Blood, 84, 3212–3220.Google Scholar
  38. 38.
    Schultz, K. R., Green, G. J., Wensley, D., Sargent, M. A., Magee, J. F., Spinelli, J. J., et al. (1994). Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood, 84, 3212–3220.PubMedGoogle Scholar
  39. 39.
    Kurland, G., & Michelson, P. (2005). Bronchiolitis obliterans in children. Pediatric Pulmonology, 39, 193–208.PubMedGoogle Scholar
  40. 40.
    Mauad, T., & Dolhnikoff, M. (2002). Histology of childhood bronchiolitis obliterans. Pediatric Pulmonology, 33, 466–474.PubMedGoogle Scholar
  41. 41.
    Leneveu, H., Brémont, F., Rubie, H., Peyroulet, M. C., Broué, A., Suc, A., et al. (1999). Respiratory function in children undergoing bone marrow transplantation. Pediatric Pulmonology, 28, 31–38.PubMedGoogle Scholar
  42. 42.
    Wieringa, J., van Kralingen, K. W., Sont, J. K., & Bresters, D. (2005). Pulmonary function impairment in children following hematopoietic stem cell transplantation. Pediatric Blood & Cancer, 45, 318–323.Google Scholar
  43. 43.
    Hoffmeister, P. A., Madtes, D. K., Storer, B. E., & Sanders, J. E. (2006). Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatric Blood & Cancer, 47, 594–606.Google Scholar
  44. 44.
    Ratjen, F., Rjabko, O., & Kremens, B. (2005). High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplantation, 36, 135–138.PubMedGoogle Scholar
  45. 45.
    Patey-Mariaud de Serre, N., Reijasse, D., Verkarre, V., Canioni, D., Colomb, V., Haddad, E., et al. (2002). Chronic intestinal graft-versus-host disease: Clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplantation, 29, 223–230.PubMedGoogle Scholar
  46. 46.
    Akpek, G., Valladares, J. L., Lee, L., Margolis, J., & Vogelsang, G. B. (2001). Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplantation, 27, 163–166.PubMedGoogle Scholar
  47. 47.
    McDonald, G. B., Shulman, H. M., Sullivan, K. M., & Spencer, G. D. (2001). Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology, 90, 770–784.Google Scholar
  48. 48.
    Tomás, J. F., Pinilla, I., García-Buey, M. L., García, A., Figuera, A., Gómez-García de Soria, V. G. G., et al. (2000). Long-term liver dysfunction after allogeneic bone marrow transplantation: Clinical features and course in 61 patients. Bone Marrow Transplantation, 26, 649–655.PubMedGoogle Scholar
  49. 49.
    Bresters, D., Van Gils, I. C., Dekker, F. W., Lankester, A. C., Bredius, R. G., & Schweizer, J. J. (2008). Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: Prevalence and risk factors. Bone Marrow Transplantation, 41, 27–31.PubMedGoogle Scholar
  50. 50.
    Locasciulli, A., Testa, M., Valsecchi, M. G., Vecchi, L., Longoni, D., Sparano, P., et al. (1997). Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: A 10-year prospective study. Blood, 90, 3799–3805.PubMedGoogle Scholar
  51. 51.
    Strasser, S. I., Sullivan, K. M., Myerson, D., Spurgeon, C. L., Storer, B., Schoch, H. G., et al. (1999). Cirrhosis of the liver in long-term marrow transplant survivors. Blood, 93, 3259–3266.PubMedGoogle Scholar
  52. 52.
    Strasser, S. I., Myerson, D., Spurgeon, C. L., Sullivan, K. M., Storer, B., Schoch, H. G., et al. (1999). Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up. Hepatology, 29, 1893–1899.PubMedGoogle Scholar
  53. 53.
    Ivantes, C. A., Amarante, H., Ioshii, S. O., & Pasquini, R. (2004). Hepatitis C virus in long-term bone marrow transplant survivors. Bone Marrow Transplantation, 33, 1181–1185.PubMedGoogle Scholar
  54. 54.
    McKay, P. J., Murphy, J. A., Cameron, S., Burnett, A. K., Campbell, M., Tansey, P., et al. (1996). Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplantation, 17, 63–66.PubMedGoogle Scholar
  55. 55.
    Strasser, S. I., Kowdley, K. V., Sale, G. E., & McDonald, G. B. (1998). Iron overload in bone marrow transplant recipients. Bone Marrow Transplantation, 22, 167–173.PubMedGoogle Scholar
  56. 56.
    Shulman, H. M., Sharma, P., Amos, D., Fenster, L. F., & McDonald, G. B. (1988). A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology, 8, 463–470.PubMedGoogle Scholar
  57. 57.
    Strasser, S. I., Shulman, H. M., Flowers, M. E., Reddy, R., Margolis, D. A., Prumbaum, M., et al. (2000). Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis. Hepatology, 32, 1265–1271.PubMedGoogle Scholar
  58. 58.
    Sudour, H., Mainard, L., Baumann, C., Clement, L., Salmon, A., & Bordigoni, P. (2009). Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplantation, 43, 127–132.PubMedGoogle Scholar
  59. 59.
    Kami, M., Hamaki, T., & Kishi, Y. (2000). Hepatic iron concentration and total body iron stores in thalassemia major. New England Journal of Medicine, 343, 1657.PubMedGoogle Scholar
  60. 60.
    Tomas, J. F., Pinilla, I., Garcia-Buey, M. L., Garcia, A., Figera, A., Gomez-Garcia de Soria, V. G. G., et al. (2000). Long term liver dysfunction after allogeneic bone marrow transplantation: Clinical features and course in 61 patients. Bone Marrow Transplantation, 26, 649–655.PubMedGoogle Scholar
  61. 61.
    Kornreich, L., Horev, G., Yaniv, I., Stein, J., Grunebaum, M., & Zaizov, R. (1997). Iron overload following bone marrow transplantation in children: MR findings. Pediatric Radiology, 27, 869–872.PubMedGoogle Scholar
  62. 62.
    Ho, G. T., Parker, A., MacKenzie, J. F., Morris, A. J., & Stnaley, A. J. (2004). Abnormal liver function tests following bone marrow transplantation: Aetiology and role of liver biopsy. European Journal of Gastroenterology and Hepatology, 16, 157–162.PubMedGoogle Scholar
  63. 63.
    Gandon, Y., Guyader, D., Heautot, J. F., Reda, M. I., Yaouanq, J., Buhé, T., et al. (1994). Hemochromatosis: Diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology, 193, 533–538.PubMedGoogle Scholar
  64. 64.
    Villeneuve, J. P., Bilodeau, M., Lepage, R., Cote, J., & Lefebvre, M. (1996). Variability in hepatic iron concentration measurement from needle-biopsy specimen. Journal of Hepatology, 25, 172–177.PubMedGoogle Scholar
  65. 65.
    Khouri, I. F., Ippoliti, C., Gajewski, J., Przepiorka, D., & Champlin, R. E. (1996). Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin. American Journal of Hematology, 52, 313–315.PubMedGoogle Scholar
  66. 66.
    Au, W. Y., Lo, C. M., Hawkins, B. R., Ma, E. S., Lie, A. K., & Kwong, Y. L. (2001). Evans’ syndrome complicating chronic graft versus host disease after cadaveric liver transplantation. Transplantation, 72, 527–528.PubMedGoogle Scholar
  67. 67.
    Tomonari, A., Tojo, A., Lseki, T., Ooi, J., Nagayama, H., Ogami, K., et al. (2001). Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia. International Journal of Hematology, 74, 228–232.PubMedGoogle Scholar
  68. 68.
    Szabolcs, P., & Niedzwiecki, D. (2008). Immune reconstitution in children after unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 14, 1317–1318.Google Scholar
  69. 69.
    Faraci, M., Békássy, A. N., De Fazio, V., Tichelli, A., Dini, G., & EBMT Paediatric and Late Effects Working Parties. (2008). Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplantation, 41, S49–S57.Google Scholar
  70. 70.
    Szabolcs, P., & Niedzwiecki, D. (2007). Immune reconstitution after unrelated cord blood transplantation. Cytotherapy, 9, 111–122.PubMedCentralPubMedGoogle Scholar
  71. 71.
    Brown, J. A., & Boussiotis, V. A. (2008). Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution. Clinical Immunology, 127, 286–297.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Socie, G., Salooja, N., Cohen, A., Rovelli, A., Carreras, E., Locasciulli, A., et al. (2003). Non-malignant late effects after allogeneic stem cell transplantation. Blood, 101, 3373–3385.PubMedGoogle Scholar
  73. 73.
    Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., et al. (2009). Center for International Blood and Marrow Research; National Marrow Donor program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Disease Canada; Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biology of Blood and Marrow Transplantation, 15, 1143–1238.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Martires, K. J., Baird, K., Steinberg, S. M., Grkovic, L., Joe, G. O., Williams, K. M., et al. (2011). Sclerotic-type chronic graft-versus-host disease of the skin: Clinical risk factors, laboratory markers, and burden of disease. Blood, 118, 4250–4257.PubMedCentralPubMedGoogle Scholar
  75. 75.
    Ferry, C., Gemayel, G., Rocha, V., Labopin, M., Esperou, H., Robin, M., et al. (2007). Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplantation, 40, 219–224.PubMedGoogle Scholar
  76. 76.
    Leung, W., Ahn, H., Rose, S. R., Phipps, S., Smith, T., Gan, K., et al. (2007). A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore), 86, 215–224.Google Scholar
  77. 77.
    Van Kempen-Harteveld, M. L., Struikmans, H., Kal, H. B., van der Tweel, I., Mourits, M. P., Verdonck, L. F., et al. (2002). Cataract after total body irradiation and bone marrow transplantation: Degree of visual impairment. International Journal of Radiation Oncology, Biology, and Physics, 52, 1375.Google Scholar
  78. 78.
    Van Kempen-Harteveld, M. L., Belkacémi, Y., Kal, H. B., Labopin, M., & Frassoni, F. (2002). Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia. International Journal of Radiation Oncology, Biology, and Physics, 52, 1367.Google Scholar
  79. 79.
    Hölttä, P., Hovi, L., Saarinen-Pihkala, U. M., Peltola, J., & Alaluusua, S. (2005). Disturbed root development of permanent teeth after pediatric stem cell transplantation. Cancer, 103, 1484.PubMedGoogle Scholar
  80. 80.
    Hölttä, P., Alaluusua, S., Saarinen-Pihkala, U. M., Peltola, J., & Hovi, L. (2005). Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer, 103, 181–190.PubMedGoogle Scholar
  81. 81.
    Pajari, U., & Lanning, M. (1995). Developmental defects of teeth in survivors of childhood ALL are related to the therapy and age at diagnosis. Medical and Pediatric Oncology, 24, 310–314.PubMedGoogle Scholar
  82. 82.
    Uderzo, C., Fraschini, D., Balduzzi, A., Galimberti, S., Arrigo, C., Biagi, E., et al. (1997). Long-term effects of bone marrow transplantation on dental status in children with leukaemia. Bone Marrow Transplantation, 20, 865–869.PubMedGoogle Scholar
  83. 83.
    Bågesund, M., Winiarski, J., & Dahllöf, G. (2000). Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation. Transplantation, 69, 822–826.PubMedGoogle Scholar
  84. 84.
    Treister, N. S., Woo, S. B., O’Holleran, E. W., Lehmann, L. E., Parsons, S. K., & Guinan, E. C. (2005). Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 721–731.PubMedGoogle Scholar
  85. 85.
    Imanguli, M. M., Pavletic, S. Z., Guadagnini, J. P., Brahim, J. S., & Atkinson, J. C. (2006). Chronic graft versus host disease of oral mucosa: Review of available therapies. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101, 175–183.PubMedGoogle Scholar
  86. 86.
    Armenian, S. H., Sun, C. L., Kawashima, T., Arora, M., Leisenring, W., Sklar, C. A., et al. (2011). Long-term health-related outcomes in survivors of childhood cancer treated with hematopoietic cell transplantation (HCT) versus conventional therapy: A report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. doi:10.1182/blood-2011-01-331835.Google Scholar
  87. 87.
    Lowe, T., Bhatia, S., & Somlo, G. (2007). Second malignancies after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 13, 1121–1134.PubMedGoogle Scholar
  88. 88.
    Socie, G., Curtis, R. E., Deeg, H. J., Sobocinski, K. A., Filipovich, A. H., Travis, L. B., et al. (2000). New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. Journal of Clinical Oncology, 18, 348–357.PubMedGoogle Scholar
  89. 89.
    Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socie, G., Travis, L. B., et al. (1997). Solid cancers after bone marrow transplantation. New England Journal of Medicine, 336, 897–904.PubMedGoogle Scholar
  90. 90.
    Kolb, H. J., Socie, G., Duell, T., Van Lint, M. T., Tichelli, A., Apperley, J. F., et al. (1999). Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Annals of Internal Medicine, 131, 738–744.PubMedGoogle Scholar
  91. 91.
    Baker, K. S., DeFor, T. E., Burns, L. J., Ramsay, N. K., Neglia, J. P., & Robison, L. L. (2003). New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. Journal of Clinical Oncology, 21, 1352–1358.PubMedGoogle Scholar
  92. 92.
    Leisenring, W., Friedman, D. L., Flowers, M. E., Schwartz, J. L., & Deeg, H. J. (2006). Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. Journal of Clinical Oncology, 24, 1119–1126.PubMedGoogle Scholar
  93. 93.
    Leiper, A. D. (2002). Non-endocrine late complications of bone marrow transplantation in childhood: Part II. British Journal of Haematology, 118, 23–43.PubMedGoogle Scholar
  94. 94.
    Rizzo, J. D., Wingard, J. R., Tichelli, A., Lee, S. J., Van Lint, M. T., Burns, L. J., et al. (2006). Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 12, 138–151.PubMedGoogle Scholar
  95. 95.
    Sanders, J. E., Hawley, J., Levy, W., Gooley, T., Buckner, C. D., Deeg, H. J., et al. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87, 3045–3052.PubMedGoogle Scholar
  96. 96.
    Brennan, B. M., & Shalet, S. M. (2002). Endocrine late effects after bone marrow transplant. British Journal of Haematology, 118, 58–66.PubMedGoogle Scholar
  97. 97.
    Bakker, B., Oostdijk, W., Bresters, D., Walenkamp, M. J., Vossen, J. M., & Wit, J. M. (2004). Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplantation, 33, 1049–1056.Google Scholar
  98. 98.
    Cohen, A., Rovelli, A., Bakker, B., Uderzo, C., van Lint, M. T., Esperou, H., et al. (1999). Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: A study by the Working Party for Late Effects-EBMT. Blood, 93, 4109–4115.PubMedGoogle Scholar
  99. 99.
    Sanders, J. E., Guthrie, K. A., Hoffmeister, P. A., Woolfrey, A. E., Carpenter, P. A., & Appelbaum, F. R. (2005). Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood, 105, 1348–1354.PubMedGoogle Scholar
  100. 100.
    Brauner, R., Adan, L., Souberbielle, J. C., Esperou, H., Michon, J., Devergie, A., et al. (1997). Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. The Journal of Pediatrics, 130, 785–792.PubMedGoogle Scholar
  101. 101.
    Thomas, B. C., Stanhope, R., Plowman, P. N., & Leiper, A. D. (1993). Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. European Journal of Pediatrics, 152, 888–892.PubMedGoogle Scholar
  102. 102.
    Sanders, J. E., Buckner, C. D., Sullivan, K. M., Doney, K., Appelbaum, F., Witherspoon, R., et al. (1988). Growth and development in children after bone marrow transplantation. Hormone Research, 30, 92–97.PubMedGoogle Scholar
  103. 103.
    Afify, Z., Shaw, P. J., Clavano-Harding, A., & Cowell, C. T. (2000). Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplantation, 25, 1087–1092.PubMedGoogle Scholar
  104. 104.
    Giorgiani, G., Bozzola, M., Locatelli, F., Picco, P., Zecca, M., Cisternino, M., et al. (1995). Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood, 86, 825–831.PubMedGoogle Scholar
  105. 105.
    Bakker, B., Oostdijk, W., Geskus, R. B., Stokvis-Brantsma, W. H., Vossen, J. M., & Wit, J. M. (2007). Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clinical Endocrinology, 67, 589–597.PubMedGoogle Scholar
  106. 106.
    Chemaitilly, W., Boulad, F., Heller, G., Kernan, N. A., Small, T. N., O’Reilly, R. J., et al. (2007). Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplantation, 40, 29–35.PubMedGoogle Scholar
  107. 107.
    Couto-Silva, A. C., Trivin, C., Esperou, H., Michon, J., Baruchel, A., Lemaire, P., et al. (2006). Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplantation, 38, 427–432.PubMedGoogle Scholar
  108. 108.
    Brownstein, C. M., Mertens, A. C., Mitby, P. A., Stovall, M., Qin, J., Heller, G., et al. (2004). Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. The Journal of Clinical Endocrinology and Metabolism, 89, 4422–4427.PubMedGoogle Scholar
  109. 109.
    Laughton, S. J., Merchant, T. E., Sklar, C. A., Kun, L. E., Fouladi, M., Broniscer, A., et al. (2008). Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. Journal of Clinical Oncology, 26, 1112–1118.PubMedGoogle Scholar
  110. 110.
    Isfan, F., Kanold, J., Merlin, E., Contet, A., Sirvent, N., Rochette, E., et al. (2011). Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: A report from the French Leukaemia Long-Term Follow-Up Study (LEA). Bone Marrow Transplantation. doi:10.1038/bmt.2011.139.PubMedGoogle Scholar
  111. 111.
    Gleeson, H. K., Stoeter, R., Ogilvy-Stuart, A. L., Gattamaneni, H. R., Brennan, B. M., & Shalet, S. M. (2003). Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. The Journal of Clinical Endocrinology and Metabolism, 88, 3682–3689.PubMedGoogle Scholar
  112. 112.
    Bakker, B., Massa, G. G., Oostdijk, W., Van Weel-Sipman, M. H., Vossen, J. M., & Wit, J. M. (2000). Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. European Journal of Pediatrics, 159, 31–37.PubMedGoogle Scholar
  113. 113.
    Shinagawa, T., Tomita, Y., Ishiguro, H.,Matsumoto, M., Shimizu, T., Yasuda, Y., et al. (2001). Final height and growth hormone secretion after bone marrow transplantation in children. Endocrine Journal, 48, 133–138.PubMedGoogle Scholar
  114. 114.
    Leung, W., Rose, S. R., Zhou, Y., Hancock, M. L., Burstein, S., Schriock, E. A., et al. (2002). Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 2959–2964.PubMedGoogle Scholar
  115. 115.
    Mackenzie, S., Craven, T., Gattamaneni, H. R.,Swindell, R., Shalet, S. M., & Brabant, G. (2011). Long-term safety of growth hormone replacement after CNS irradiation. The Journal of Clinical Endocrinology and Metabolism, 96, 2756–2761.PubMedGoogle Scholar
  116. 116.
    Darendeliler, F., Karagiannis, G., Wilton, P., Ranke, M. B., Albertsson-Wikland, K., Anthony Price, D., et al. (2006). Recurrence of brain tumours in patients treated with growth hormone: Analysis of KIGS (Pfizer International Growth Database). Acta Paediatrica, 95, 1284–1290.PubMedGoogle Scholar
  117. 117.
    Sklar, C. A., Mertens, A. C., Mitby, P., Occhiogrosso, G., Qin, J., Heller, G., et al. (2002). Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study. The Journal of Clinical Endocrinology and Metabolism, 87, 3136–3141.PubMedGoogle Scholar
  118. 118.
    Ergun-Longmire, B., Mertens, A. C., Mitby, P., Qin, J., Heller, G., Shi, W., et al. (2006). Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. The Journal of Clinical Endocrinology and Metabolism, 91, 3494–3498.PubMedGoogle Scholar
  119. 119.
    Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011). Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 96, 1587–1609.PubMedGoogle Scholar
  120. 120.
    Follin, C., Thilen, U., Ahren, B., & Erfurth, E. M. (2006). Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. The Journal of Clinical Endocrinology and Metabolism, 91, 1872–1875.PubMedGoogle Scholar
  121. 121.
    Mukherjee, A., Tolhurst-Cleaver, S., Ryder, W. D., Smethurst, L., & Shalet, S. M. (2005). The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. The Journal of Clinical Endocrinology and Metabolism, 90, 1542–1549.PubMedGoogle Scholar
  122. 122.
    Murray, R. D., Wieringa, G. E., Lissett, C. A., Darzy, K. H., Smethurst, L.E., & Shalet, S. M. (2002). Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clinical Endocrinology, 56, 525–532.PubMedGoogle Scholar
  123. 123.
    Murray, R. D., & Shalet, S. M. (2002). Adult growth hormone replacement: Lessons learned and future direction. The Journal of Clinical Endocrinology and Metabolism, 87, 4427–4428.PubMedGoogle Scholar
  124. 124.
    Murray, R. D., Darzy, K. H., Gleeson, H. K., & Shalet, S. M. (2002). GH-deficient survivors of childhood cancer: GH replacement during adult life. The Journal of Clinical Endocrinology and Metabolism, 87, 129–135.PubMedGoogle Scholar
  125. 125.
    van den Heijkant, S., Hoorweg-Nijman, G., Huisman, J., Drent, M., van der Pal, H., Kaspers, G. J., et al. (2011). Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 33, e231–e238.PubMedGoogle Scholar
  126. 126.
    Carter, J., Raviv, L., Applegarth, L., Ford, J. S., Josephs, L., Grill, E., et al. (2010). A cross-sectional study of the psychosexual impact of cancer-related infertility in women: Third-party reproductive assistance. Journal of Cancer Survivorship, 4, 236–246.PubMedCentralPubMedGoogle Scholar
  127. 127.
    Mosher, C. E., Duhamel, K. N., Rini, C., Corner, G., Lam, J., & Redd, W. H. (2011). Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer, 19, 1357–1365.PubMedCentralPubMedGoogle Scholar
  128. 128.
    Abou-Mourad, Y. R., Lau, B. C., Barnett, M. J., Forrest, D. L., Hogge, D. E., Nantel, S. H., et al. (2010). Long-term outcome after allo-SCT: Close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplantation, 45, 295–302.PubMedGoogle Scholar
  129. 129.
    Tauchmanova, L., Selleri, C., Rosa, G. D., Pagano, L., Orio, F., Lombardi, G., et al. (2002). High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer, 95, 1076–1084.PubMedGoogle Scholar
  130. 130.
    Morales, A., Bella, A. J., Chun, S., Lee, J., Assimakopoulos, P., Bebb, R., et al. (2010). A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Canadian Urological Association Journal, 4, 269–275.PubMedCentralPubMedGoogle Scholar
  131. 131.
    Ness, K. K., Leisenring, W., Goodman, P., Kawashima, T., Mertens, A. C., Oeffinger, K. C., et al. (2009). Assessment of selection bias in clinic-based populations of childhood cancer survivors: A report from the childhood cancer survivor study. Pediatric Blood & Cancer, 52, 379–386.Google Scholar
  132. 132.
    Green, D. M., Kawashima, T., Stovall, M., Leisenring, W., Sklar, C. A., Mertens, A. C., et al. (2009). Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. Journal of Clinical Oncology, 27, 2677–2685.PubMedCentralPubMedGoogle Scholar
  133. 133.
    Sklar, C. (2005). Maintenance of ovarian function and risk of premature menopause related to cancer treatment. Journal of the National Cancer Institute Monographs, 2005, 25–27.Google Scholar
  134. 134.
    Howell, S. J., & Shalet, S. M. (2005). Spermatogenesis after cancer treatment: Damage and recovery. Journal of the National Cancer Institute Monographs, 12–17.Google Scholar
  135. 135.
    Howell, S. J., & Shalet, S. M. (2001). Testicular function following chemotherapy. Human Reproduction Update, 7, 363–369.PubMedGoogle Scholar
  136. 136.
    Green, D. M., Sklar, C. A., Boice, J. D., Jr., Mulvihill, J. J., Whitton, J. A., Stovall, M., et al. (2009). Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 27, 2374–2381.PubMedCentralPubMedGoogle Scholar
  137. 137.
    Cohen, A., Bekassy, A. N., Gaiero, A., Faraci, M., Zecca, S., Tichelli, A., et al. (2008). Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplantation, 41(Suppl 2), S43–S48.PubMedGoogle Scholar
  138. 138.
    Fish, J. D. (2011). Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure–when is it worth the risk? Journal of Pediatric and Adolescent Gynecology, 24, 98–101.PubMedGoogle Scholar
  139. 139.
    Hershlag, A., Rausch, M. E., & Cohen, M. (2011). Part 2: Ovarian failure in adolescent cancer survivors should be treated. Journal of Pediatric and Adolescent Gynecology, 24, 101–103.PubMedGoogle Scholar
  140. 140.
    Liu, J., Malhotra, R., Voltarelli, J., Stracieri, A. B., Oliveira, L., Simoes, B. P., et al. (2008). Ovarian recovery after stem cell transplantation. Bone Marrow Transplantation, 41, 275–278.PubMedGoogle Scholar
  141. 141.
    Kenney, L. B., Laufer, M. R., Grant, F. D., Grier, H., & Diller, L. (2001). High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer, 91, 613–621.PubMedGoogle Scholar
  142. 142.
    Borgmann-Staudt, A., Rendtorff, R., Reinmuth, S., Hohmann, C., Keil, T., Schuster, F. R., et al. (2011). Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplantation. doi:10.1038/bmt.2011.78.PubMedGoogle Scholar
  143. 143.
    Wallace, W. H., Shalet, S. M., Hendry, J. H., Morris-Jones, P. H., & Gattamaneni, H. R. (1989). Ovarian failure following abdominal irradiation in childhood: The radiosensitivity of the human oocyte. The British Journal of Radiology, 62, 995–998.PubMedGoogle Scholar
  144. 144.
    Goldman, S., & Johnson, F. L. (1993). Effects of chemotherapy and irradiation on the gonads. Endocrinology and Metabolism Clinics of North America, 22, 617–629.PubMedGoogle Scholar
  145. 145.
    Green, D. M., Nolan, V. G., Kawashima, T., Stovall, M., Donaldson, S. S., Srivastava, D., et al. (2011). Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: A report from the Childhood Cancer Survivor Study. Fertility and Sterility, 95, 1922–1927.PubMedCentralPubMedGoogle Scholar
  146. 146.
    Borgna-Pignatti, C., Marradi, P., Rugolotto, S., & Marcolongo, A. (1996). Successful pregnancy after bone marrow transplantation for thalassaemia. Bone Marrow Transplantation, 18, 235–236.PubMedGoogle Scholar
  147. 147.
    Singhal, S., Powles, R., Treleaven, J., Horton, C., Swansbury, G. J., & Mehta, J. (1996). Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: Alloengraftment with potential preservation of fertility in women. Bone Marrow Transplantation, 18, 1049–1055.PubMedGoogle Scholar
  148. 148.
    Maruta, A., Matsuzaki, M., Miyashita, H., Kodama, F., Kato, H., Taguchi, J., et al. (1995). Successful pregnancy after allogeneic bone marrow transplantation following conditioning with total body irradiation. Bone Marrow Transplantation, 15, 637–638.PubMedGoogle Scholar
  149. 149.
    Wang, W. S., Tzeng, C. H., Hsieh, R. K., Chiou, T. J., Liu. J. H., Yen, C. C., et al. (1998). Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia. Bone Marrow Transplantation, 21, 415–417.Google Scholar
  150. 150.
    Salooja, N., Szydlo, R. M., Socie, G., Rio, B., Chatterjee, R., Ljungman P., et al. (2001). Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet, 358, 271–276.PubMedGoogle Scholar
  151. 151.
    Critchley, H. O., Wallace, W. H., Shalet, S. M., Mamtora, H., Higginson, J., & Anderson, D. C. (1992). Abdominal irradiation in childhood; the potential for pregnancy. British Journal of Obstetrics and Gynaecology, 99, 392–394.PubMedGoogle Scholar
  152. 152.
    West, E. R., Zelinski, M. B., Kondapalli, L. A., Gracia, C., Chang, J., Coutifaris, C., et al. (2009). Preserving female fertility following cancer treatment: Current options and future possibilities. Pediatric Blood & Cancer, 53, 289–295.Google Scholar
  153. 153.
    Berger, C., Le-Gallo, B., Donadieu, J., Richard, O., Devergie, A., Galambrun, C., et al. (2005). Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplantation, 35, 991–995.PubMedGoogle Scholar
  154. 154.
    Chow, E. J., Friedman, D. L., Stovall, M., Yasui, Y., Whitton, J. A., Robison, L. L., et al. (2009). Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Pediatric Blood & Cancer, 53, 432–437.Google Scholar
  155. 155.
    DeGroot, L. J. (1993). Effects of irradiation on the thyroid gland. Endocrinology and Metabolism Clinics of North America, 22, 607–615.PubMedGoogle Scholar
  156. 156.
    Borgstrom, B., & Bolme, P. (1994). Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 13, 59–64.PubMedGoogle Scholar
  157. 157.
    Slatter, M. A., Gennery, A. R., Cheetham, T. D., Bhattacharya, A., Crooks, B. N., Flood, T. J., et al. (2004). Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplantation, 33, 949–953.PubMedGoogle Scholar
  158. 158.
    Baker, K. S., Gurney, J. G., Ness, K. K., Bhatia, R., Forman, S. J., Francisco, L., et al. (2004). Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: Results from the Bone Marrow Transplant Survivor Study. Blood, 104, 1898–1906.PubMedGoogle Scholar
  159. 159.
    Livesey, E. A., & Brook, C. G. (1989). Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Archives of Disease in Childhood, 64, 593–595.PubMedCentralPubMedGoogle Scholar
  160. 160.
    Rose, S. R., Lustig, R. H., Pitukcheewanont, P., Broome, D. C., Burghen, G. A., Li, H., et al. (1999). Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. The Journal of Clinical Endocrinology and Metabolism, 84, 4472–4479.PubMedGoogle Scholar
  161. 161.
    Aldouri, M. A., Ruggier, R., Epstein, O., & Prentice, H. G. (1990). Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. British Journal of Haematology, 74, 118–119.PubMedGoogle Scholar
  162. 162.
    Berisso, G. A., van Lint, M. T., Bacigalupo, A., & Marmont, A. M. (1999). Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves’ disease. Bone Marrow Transplantation, 23, 1091–1092.PubMedGoogle Scholar
  163. 163.
    Tailor, I. K., Akil, M., Rennie, I., Ross, R. J., & Snowden, J. A. (2011). Reconstitution Graves’ disease following autologous haematopoietic stem cell transplantation for severe diffuse systemic sclerosis. QJM. doi:10.1093/qjmed/hcr050.PubMedGoogle Scholar
  164. 164.
    Sigurdson, A. J., Ronckers, C. M., Mertens, A. C., Stovall, M., Smith, S. A., Liu, Y., et al. (2005). Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet, 365, 2014–2023.PubMedGoogle Scholar
  165. 165.
    Stern, J. M., Chesnut, C. H., 3rd, Bruemmer, B., Sullivan, K. M., Lenssen, P. S., Aker, S. N., et al. (1996). Bone density loss during treatment of chronic GVHD. Bone Marrow Transplantation, 17, 395–400.PubMedGoogle Scholar
  166. 166.
    Stern, J. M., Sullivan, K. M., Ott, S. M., Seidel, K., Fink, J. C., Longton, G., et al. (2001). Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biology of Blood and Marrow Transplantation, 7, 257–264.PubMedGoogle Scholar
  167. 167.
    Castaneda, S., Carmona, L., Carvajal, I., Arranz, R., Diaz, A., & Garcia-Vadillo, A. (1997). Reduction of bone mass in women after bone marrow transplantation. Calcified Tissue International, 60, 343–347.PubMedGoogle Scholar
  168. 168.
    Bhatia, S., Ramsay, N. K., Weisdorf, D., Griffiths, H., & Robison, L. L. (1998). Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplantation, 22, 87–90.PubMedGoogle Scholar
  169. 169.
    Nysom, K., Holm, K., Michaelsen, K. F., Hertz, H., Jacobsen, N., Muller, J., et al. (2000). Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplantation, 25, 191–196.PubMedGoogle Scholar
  170. 170.
    Kaste, S. C., Shidler, T. J., Tong, X., Srivastava, D. K., Rochester, R., Hudson, M. M., et al. (2004). Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplantation, 33, 435–441.PubMedGoogle Scholar
  171. 171.
    Wasilewski-Masker, K., Kaste, S. C., Hudson, M. M., Esiashvili, N., Mattano, L. A., & Meacham, L. R. (2008). Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics, 121, e705–e713.PubMedGoogle Scholar
  172. 172.
    Thomas, I. H., Donohue, J. E., Ness, K. K., Dengel, D. R., Baker, K.S., & Gurney, J. G. (2008). Bone mineral density in young adult survivors of acute lymphoblastic leukemia. Cancer, 113, 3248–3256.PubMedCentralPubMedGoogle Scholar
  173. 173.
    Grigg, A. P., Shuttleworth, P., Reynolds, J., Schwarer, A. P., Szer, J., Bradstock, K., et al. (2006). Pamidronate reduces bone loss after allogeneic stem cell transplantation. The Journal of Clinical Endocrinology and Metabolism, 91, 3835–3843.PubMedGoogle Scholar
  174. 174.
    Tauchmanova, L., De Simone, G., Musella, T., Orio, F., Ricci, P., Nappi, C., et al. (2006). Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplantation, 37, 81–88.PubMedGoogle Scholar
  175. 175.
    Tauchmanova, L., Selleri, C., Esposito, M., Di Somma, C., Orio, F., Jr., Bifulco, G., et al. (2003). Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporosis International, 14, 1013–1019.PubMedGoogle Scholar
  176. 176.
    D’Souza, A. B., Grigg, A. P., Szer, J., & Ebeling, P. R. (2006). Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. Internal Medicine Journal, 36, 600–603.PubMedGoogle Scholar
  177. 177.
    Gafni, R. I., & Baron, J. (2004). Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). The Journal of Pediatrics, 144, 253–257.PubMedGoogle Scholar
  178. 178.
    Fink, J. C., Leisenring, W. M., Sullivan, K. M., Sherrard, D. J., & Weiss, N. S. (1998). Avascular necrosis following bone marrow transplantation: A case-control study. Bone, 22, 67–71.PubMedGoogle Scholar
  179. 179.
    Faraci, M., Calevo, M. G., Lanino, E., Caruso, S., Messina, C., Favr, C., et al. (2006). Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica, 91, 1096–1099.PubMedGoogle Scholar
  180. 180.
    Socie, G., Cahn, J. Y., Carmelo, J., Vernant, J. P., Jouet, J. P., Ifrah, N., et al. (1997). Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). British Journal of Haematology, 97, 865–870.PubMedGoogle Scholar
  181. 181.
    Socie, G., Selimi, F., Sedel, L., Frija, J., Devergie, A., Esperou Bourdeau, H., et al. (1994). Avascular necrosis of bone after allogeneic bone marrow transplantation: Clinical findings, incidence and risk factors. British Journal of Haematology, 86, 624–628.PubMedGoogle Scholar
  182. 182.
    French, D., Hamilton, L. H., Mattano, L. A., Jr., Sather, H. N., Devidas, M., Nachman, J. B., et al. (2008). A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: A report from the Children’s Oncology Group. Blood, 111, 4496–4499.PubMedCentralPubMedGoogle Scholar
  183. 183.
    Wilkinson, J. M., & Little, D. G. (2011). Bisphosphonates in orthopedic applications. Bone, 49, 95–102.PubMedGoogle Scholar
  184. 184.
    Cardozo, J. B., Andrade, D. M., & Santiago, M. B. (2008). The use of bisphosphonate in the treatment of avascular necrosis: A systematic review. Clinical Rheumatology, 27, 685–688.PubMedGoogle Scholar
  185. 185.
    Sklar, C. A., Mertens, A. C., Walter, A., Mitchell, D., Nesbit, M. E., O’Leary, M., et al. (2000). Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: Role of cranial irradiation. Medical and Pediatric Oncology, 35, 91–95.PubMedGoogle Scholar
  186. 186.
    Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Yasui, Y., Fears T., Stovall, M., et al. (2003). Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 21, 1359–1365.PubMedGoogle Scholar
  187. 187.
    Frisk, P., Rossner, S. M., Norgren, S., Arvidson, J., & Gustafsson, J. (2011). Glucose metabolism and body composition in young adults treated with TBI during childhood. Bone Marrow Transplantation, 46, 1303–1308.PubMedGoogle Scholar
  188. 188.
    Tomita, Y., Ishiguro, H., Yasuda, Y., Hyodo, H., Koike, T., Shimizu, T., et al. (2011). High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. Bone Marrow Transplantation, 46, 416–425.PubMedGoogle Scholar
  189. 189.
    Annaloro, C., Usardi, P., Airaghi, L., Giunta, V., Forti, S., Orsatti, A., et al. (2008). Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplantation, 41, 797–804.PubMedGoogle Scholar
  190. 190.
    Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). (2001). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486–2497.Google Scholar
  191. 191.
    Majhail, N. S., Flowers, M. E., Ness, K. K., Jagasia, M., Carpenter, P. A., Arora, M., et al. (2009). High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 43, 49–54.PubMedCentralPubMedGoogle Scholar
  192. 192.
    Oudin, C., Simeoni, M. C., Sirvent, N., Contet, A., Begu-Le Coroller, A., Bordigoni, P., et al. (2011). Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood, 117, 4442–4448.PubMedGoogle Scholar
  193. 193.
    Shalitin, S., Phillip, M., Stein, J., Goshen, Y., Carmi, D., & Yaniv, I. (2006). Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplantation, 37, 1109–1117.PubMedGoogle Scholar
  194. 194.
    Airaghi, L., Usardi, P., Forti, S., Orsatti, A., Baldini, M., Annaloro, C., et al. (2011). A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome. Journal of Endocrinological Investigation, 34, e6–e11.PubMedGoogle Scholar
  195. 195.
    Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Jr., Ruccione, K., et al. (2001). Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. Journal of Clinical Oncology, 19, 3163–3172.PubMedGoogle Scholar
  196. 196.
    Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., et al. (2006). Chronic health conditions in adult survivors of childhood cancer. New England Journal of Medicine, 355, 1572–1582.PubMedGoogle Scholar
  197. 197.
    Taskinen, M., Saarinen-Pihkala, U. M., Hovi, L., & Lipsanen-Nyman, M. (2000). Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet, 356, 993–997.PubMedGoogle Scholar
  198. 198.
    Hoffmeister, P. A., Storer, B. E., & Sanders, J. E. (2004). Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. Journal of Pediatric Hematology/Oncology, 26, 81–90.PubMedGoogle Scholar
  199. 199.
    Traggiai, C., Stanhope, R., Nussey, S., & Leiper, A. D. (2003). Diabetes mellitus after bone marrow transplantation during childhood. Medical and Pediatric Oncology, 40, 128–129.PubMedGoogle Scholar
  200. 200.
    Baker, K. S., Ness, K. K., Steinberger, J., Carter, A., Francisco, L., Burns, L. J., et al. (2007). Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood, 109, 1765–1772.PubMedGoogle Scholar
  201. 201.
    Meacham, L. R., Sklar, C. A., Li, S., Liu, Q., Gimpel, N., Yasui, Y., et al. (2009). Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the childhood cancer survivor study. Archives of Internal Medicine, 169, 1381–1388.PubMedCentralPubMedGoogle Scholar
  202. 202.
    Chemaitilly, W., Boulad, F., Oeffinger, K. C., & Sklar, C. A. (2009). Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: A pilot study. Bone Marrow Transplantation, 44, 339–343.PubMedGoogle Scholar
  203. 203.
    Lorini, R., Cortona, L., Scaramuzza, A., De Stefano, P., Locatelli, F., Bonetti, F., et al. (1995). Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplantation, 15, 873–877.PubMedGoogle Scholar
  204. 204.
    Tonorezos, E. S., Vega, G. L., Sklar, C. A., Chou, J. F., Moskowitz, C. S., Mo, Q., et al. (2011). Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatric Blood & Cancer. doi:10.1002/pbc.22964.Google Scholar
  205. 205.
    Bonanomi, S., Gaiero, A., Masera, N., Rovelli, A., Uderzo, C., Fichera, G., et al. (2006). Distinctive characteristics of diabetes mellitus after hematopoietic cell transplantation during childhood. Pediatric Transplantation, 10, 461–465.PubMedGoogle Scholar
  206. 206.
    Uderzo, C., Pillon, M., Corti, P., Tridello, G., Tana, F., Zintl, F., et al. (2007). Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: A prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplantation, 39, 667–675.PubMedGoogle Scholar
  207. 207.
    Baker, K. S., Bresters, D., & Sande, J. E. (2010). The burden of cure: Long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatric Clinics of North America, 57, 323–342.PubMedGoogle Scholar
  208. 208.
    Armenian, S. H., Sun, C. L., Mills, G., Teh, J. B., Francisco, L., Durand, J. B., et al. (2010). Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 16, 1138–1144.PubMedCentralPubMedGoogle Scholar
  209. 209.
    Hudson, M., Landier, W., Eshelman, D., Forte, K., Darling, J., Hester, A. L., et al. (2009). Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Children’s Oncology Group. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdfGoogle Scholar
  210. 210.
    Kist-van Holthe, J. E., Goedvolk, C. A., Brand, R., van Weel, M. H., Bredius, R. G., van Oostayen, J. A., et al. (2002). Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology, 17, 1032–1037.PubMedGoogle Scholar
  211. 211.
    Frisk, P., Bratteby, L. E., Carlson, K., & Lonnerholm, G. (2002). Renal function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplantation, 29, 129–136.PubMedGoogle Scholar
  212. 212.
    Abboud, I., Porcher, R., Robin, M., de Latour, R. P., Glotz, D., Socie, G., et al. (2009). Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 15, 1251–1257.PubMedGoogle Scholar
  213. 213.
    Choi, M., Sun, C. L., Kurian, S., Carter, A., Francisco, L., Forman, S. J., et al. (2008). Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer, 113, 1580–1587.PubMedCentralPubMedGoogle Scholar
  214. 214.
    Phipps, S., Rai, S. N., Leung, W. H., Lensing, S., & Dunavant, M. (2008). Cognitive and academic consequences of stem-cell transplantation in children. Journal of Clinical Oncology, 26, 2027–2033.PubMedGoogle Scholar
  215. 215.
    Simms, S., Kazak, A. E., Golomb, V., Goldwein, J., & Bunin, N. (2002). Cognitive, behavioral, and social outcome in survivors of childhood stem cell transplantation. Journal of Pediatric Hematology/Oncology, 24, 115–119.PubMedGoogle Scholar
  216. 216.
    Kramer, J. H., Crittenden, M. R., DeSantes, K., Cowan, M. J. (1997). Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplantation, 19, 607–613.PubMedGoogle Scholar
  217. 217.
    Clarke, S. A., Eiser, C., & Skinner, R. (2008). Health-related quality of life in survivors of BMT for paediatric malignancy: A systematic review of the literature. Bone Marrow Transplantation, 42, 73–82.PubMedGoogle Scholar
  218. 218.
    Packman, W., Weber, S., Wallace, J., Bugescu, N. (2010). Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: A review. Bone Marrow Transplantation, 45, 1134–1146.PubMedGoogle Scholar
  219. 219.
    Tallman, B., Shaw, K., Schultz, J., & Altmaier, E. (2010). Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: A nine-year longitudinal study. Rehabilitation Psychology, 55, 204–210.PubMedGoogle Scholar
  220. 220.
    Ness, K. K., Bhatia, S., Baker, K. S., Francisco, L., Carter, A., Forman, S. J., et al. (2005). Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: The bone marrow transplant survivor study. Archives of Pediatrics and Adolescent Medicine, 159, 706–713.PubMedGoogle Scholar
  221. 221.
    Lof, C. M., Winiarski, J., Giesecke, A., Ljungman, P., & Forinder, U. (2009). Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplantation, 43, 461–468.PubMedGoogle Scholar
  222. 222.
    Lof, C. M., Winiarski, J., Ljungman, P., , Forinder, U. (2011). The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatric Transplantation. doi:10.1111/j.1399-3046.2011.01537.x.PubMedGoogle Scholar

Copyright information

© Springer New York 2015

Authors and Affiliations

  1. 1.Division of Hematology/OncologyThe Hospital for Sick ChildrenTorontoCanada
  2. 2.Division of EndocrinologyThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations